Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date

Overview of attention for article published in OncoTargets and therapy, September 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

So far, Altmetric has seen 3 citations on 3 Wikipedia pages.

Pembrolizumab (formerly MK-3475 and lambrolizumab, trade name Keytruda) is a humanized antibody used in cancer immunotherapy.